These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33632010)

  • 1. Inhibitory Effects of Combined Bone Morphogenetic Protein 2, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor on Osteoclast Differentiation and Activity.
    Wu H; Yin G; Pu X; Wang J; Liao X; Huang Z
    Tissue Eng Part A; 2021 Nov; 27(21-22):1387-1398. PubMed ID: 33632010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential application of bFGF and BMP-2 facilitates osteogenic differentiation of human periodontal ligament stem cells.
    Kang W; Liang Q; Du L; Shang L; Wang T; Ge S
    J Periodontal Res; 2019 Aug; 54(4):424-434. PubMed ID: 30851068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic and sequential effects of BMP-2, bFGF and VEGF on osteogenic differentiation of rat osteoblasts.
    Li P; Bai Y; Yin G; Pu X; Huang Z; Liao X; Chen X; Yao Y
    J Bone Miner Metab; 2014 Nov; 32(6):627-35. PubMed ID: 24306516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation.
    Wutzl A; Brozek W; Lernbass I; Rauner M; Hofbauer G; Schopper C; Watzinger F; Peterlik M; Pietschmann P
    J Biomed Mater Res A; 2006 Apr; 77(1):75-83. PubMed ID: 16355411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.
    Omi M; Kaartinen V; Mishina Y
    J Biol Chem; 2019 Nov; 294(47):17818-17836. PubMed ID: 31619522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esculetin attenuates receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation through c-Fos/nuclear factor of activated T-cells c1 signaling pathway.
    Baek JM; Park SH; Cheon YH; Ahn SJ; Lee MS; Oh J; Kim JY
    Biochem Biophys Res Commun; 2015 May; 461(2):334-41. PubMed ID: 25887803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway.
    Li L; Sapkota M; Gao M; Choi H; Soh Y
    Eur J Pharmacol; 2017 Nov; 815():202-209. PubMed ID: 28919027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth factors (BMP-4/7 & bFGF) on proliferation & osteogenic differentiation of bone marrow stromal cells.
    Yuan S; Pan Q; Fu CJ; Bi Z
    Indian J Med Res; 2013; 138(1):104-10. PubMed ID: 24056563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclastogenesis in the nonadherent cell population of human bone marrow is inhibited by rhBMP-2 alone or together with rhVEGF.
    Wan C; He Q; Li G
    J Orthop Res; 2006 Jan; 24(1):29-36. PubMed ID: 16419966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual growth factor delivery from biofunctionalized allografts: Sequential VEGF and BMP-2 release to stimulate allograft remodeling.
    Sharmin F; McDermott C; Lieberman J; Sanjay A; Khan Y
    J Orthop Res; 2017 May; 35(5):1086-1095. PubMed ID: 27155087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells.
    Hanada K; Dennis JE; Caplan AI
    J Bone Miner Res; 1997 Oct; 12(10):1606-14. PubMed ID: 9333121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
    Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
    Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade.
    Zhang L; Yang Y; Liao Z; Liu Q; Lei X; Li M; Saijilafu ; Zhang Z; Hong D; Zhu M; Li B; Yang H; Chen J
    Theranostics; 2020; 10(15):6638-6660. PubMed ID: 32550895
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relationship between the bone mass and the expressions of vascular endothelial growth factor, basic fibroblast growth factor, and bone morphogenetic protein 2 mRNA in avascular necrosis of femoral head].
    Wang W; Li S; Niu D; Liu F; Sun J; Zhang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Aug; 25(8):984-91. PubMed ID: 21923031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Morphogenetic Protein-2 Promotes Osteoclasts-mediated Osteolysis via Smad1 and p65 Signaling Pathways.
    Miao X; Yuan J; Wu J; Zheng J; Zheng W; Wang F; Wang C; Li X; Liu S; Shi Z; Li J
    Spine (Phila Pa 1976); 2021 Feb; 46(4):E234-E242. PubMed ID: 33156278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
    Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
    Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling.
    Yamashita M; Otsuka F; Mukai T; Yamanaka R; Otani H; Matsumoto Y; Nakamura E; Takano M; Sada KE; Makino H
    Regul Pept; 2010 Jun; 162(1-3):99-108. PubMed ID: 20346376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
    Kim HS; Suh KS; Sul D; Kim BJ; Lee SK; Jung WW
    Int J Mol Med; 2012 Feb; 29(2):169-77. PubMed ID: 22038020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption.
    Ha H; Shim KS; An H; Kim T; Ma JY
    BMC Complement Altern Med; 2013 May; 13():112. PubMed ID: 23692684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.